Tag Archives: Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee*

Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee*

NCCN: Cancer and COVID-19 Vaccination Version 1.0 1/22/2021 Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee*   Patients with cancer should be prioritized for vaccination (CDC priority group 1b/c) and should be immunized when vaccination is available to them.   Immunization is recommended for all patients receiving active therapy, with the understanding that there […]